Vaccine for Influenza Market, Global Outlook and Forecast 2023-2028

Report ID: 1568531 | Published Date: Feb 2026 | No. of Page: 71 | Base Year: 2025 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Introduction to Research & Analysis Reports
    1.1 Vaccine for Influenza Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Vaccine for Influenza Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Vaccine for Influenza Overall Market Size
    2.1 Global Vaccine for Influenza Market Size: 2021 VS 2028
    2.2 Global Vaccine for Influenza Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Vaccine for Influenza Sales: 2017-2028
3 Company Landscape
    3.1 Top Vaccine for Influenza Players in Global Market
    3.2 Top Global Vaccine for Influenza Companies Ranked by Revenue
    3.3 Global Vaccine for Influenza Revenue by Companies
    3.4 Global Vaccine for Influenza Sales by Companies
    3.5 Global Vaccine for Influenza Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Vaccine for Influenza Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Vaccine for Influenza Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Vaccine for Influenza Players in Global Market
        3.8.1 List of Global Tier 1 Vaccine for Influenza Companies
        3.8.2 List of Global Tier 2 and Tier 3 Vaccine for Influenza Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Vaccine for Influenza Market Size Markets, 2021 & 2028
        4.1.2 Trivalent Influenza Vaccine
        4.1.3 Quadrivalent Influenza Vaccine
    4.2 By Type - Global Vaccine for Influenza Revenue & Forecasts
        4.2.1 By Type - Global Vaccine for Influenza Revenue, 2017-2022
        4.2.2 By Type - Global Vaccine for Influenza Revenue, 2023-2028
        4.2.3 By Type - Global Vaccine for Influenza Revenue Market Share, 2017-2028
    4.3 By Type - Global Vaccine for Influenza Sales & Forecasts
        4.3.1 By Type - Global Vaccine for Influenza Sales, 2017-2022
        4.3.2 By Type - Global Vaccine for Influenza Sales, 2023-2028
        4.3.3 By Type - Global Vaccine for Influenza Sales Market Share, 2017-2028
    4.4 By Type - Global Vaccine for Influenza Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Vaccine for Influenza Market Size, 2021 & 2028
        5.1.2 For Children (6 months to 3 years)
        5.1.3 For Adults and Children over 3 years
    5.2 By Application - Global Vaccine for Influenza Revenue & Forecasts
        5.2.1 By Application - Global Vaccine for Influenza Revenue, 2017-2022
        5.2.2 By Application - Global Vaccine for Influenza Revenue, 2023-2028
        5.2.3 By Application - Global Vaccine for Influenza Revenue Market Share, 2017-2028
    5.3 By Application - Global Vaccine for Influenza Sales & Forecasts
        5.3.1 By Application - Global Vaccine for Influenza Sales, 2017-2022
        5.3.2 By Application - Global Vaccine for Influenza Sales, 2023-2028
        5.3.3 By Application - Global Vaccine for Influenza Sales Market Share, 2017-2028
    5.4 By Application - Global Vaccine for Influenza Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Vaccine for Influenza Market Size, 2021 & 2028
    6.2 By Region - Global Vaccine for Influenza Revenue & Forecasts
        6.2.1 By Region - Global Vaccine for Influenza Revenue, 2017-2022
        6.2.2 By Region - Global Vaccine for Influenza Revenue, 2023-2028
        6.2.3 By Region - Global Vaccine for Influenza Revenue Market Share, 2017-2028
    6.3 By Region - Global Vaccine for Influenza Sales & Forecasts
        6.3.1 By Region - Global Vaccine for Influenza Sales, 2017-2022
        6.3.2 By Region - Global Vaccine for Influenza Sales, 2023-2028
        6.3.3 By Region - Global Vaccine for Influenza Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Vaccine for Influenza Revenue, 2017-2028
        6.4.2 By Country - North America Vaccine for Influenza Sales, 2017-2028
        6.4.3 US Vaccine for Influenza Market Size, 2017-2028
        6.4.4 Canada Vaccine for Influenza Market Size, 2017-2028
        6.4.5 Mexico Vaccine for Influenza Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Vaccine for Influenza Revenue, 2017-2028
        6.5.2 By Country - Europe Vaccine for Influenza Sales, 2017-2028
        6.5.3 Germany Vaccine for Influenza Market Size, 2017-2028
        6.5.4 France Vaccine for Influenza Market Size, 2017-2028
        6.5.5 U.K. Vaccine for Influenza Market Size, 2017-2028
        6.5.6 Italy Vaccine for Influenza Market Size, 2017-2028
        6.5.7 Russia Vaccine for Influenza Market Size, 2017-2028
        6.5.8 Nordic Countries Vaccine for Influenza Market Size, 2017-2028
        6.5.9 Benelux Vaccine for Influenza Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Vaccine for Influenza Revenue, 2017-2028
        6.6.2 By Region - Asia Vaccine for Influenza Sales, 2017-2028
        6.6.3 China Vaccine for Influenza Market Size, 2017-2028
        6.6.4 Japan Vaccine for Influenza Market Size, 2017-2028
        6.6.5 South Korea Vaccine for Influenza Market Size, 2017-2028
        6.6.6 Southeast Asia Vaccine for Influenza Market Size, 2017-2028
        6.6.7 India Vaccine for Influenza Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Vaccine for Influenza Revenue, 2017-2028
        6.7.2 By Country - South America Vaccine for Influenza Sales, 2017-2028
        6.7.3 Brazil Vaccine for Influenza Market Size, 2017-2028
        6.7.4 Argentina Vaccine for Influenza Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Vaccine for Influenza Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Vaccine for Influenza Sales, 2017-2028
        6.8.3 Turkey Vaccine for Influenza Market Size, 2017-2028
        6.8.4 Israel Vaccine for Influenza Market Size, 2017-2028
        6.8.5 Saudi Arabia Vaccine for Influenza Market Size, 2017-2028
        6.8.6 UAE Vaccine for Influenza Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Sanofi
        7.1.1 Sanofi Corporate Summary
        7.1.2 Sanofi Business Overview
        7.1.3 Sanofi Vaccine for Influenza Major Product Offerings
        7.1.4 Sanofi Vaccine for Influenza Sales and Revenue in Global (2017-2022)
        7.1.5 Sanofi Key News
    7.2 CSL
        7.2.1 CSL Corporate Summary
        7.2.2 CSL Business Overview
        7.2.3 CSL Vaccine for Influenza Major Product Offerings
        7.2.4 CSL Vaccine for Influenza Sales and Revenue in Global (2017-2022)
        7.2.5 CSL Key News
    7.3 GSK
        7.3.1 GSK Corporate Summary
        7.3.2 GSK Business Overview
        7.3.3 GSK Vaccine for Influenza Major Product Offerings
        7.3.4 GSK Vaccine for Influenza Sales and Revenue in Global (2017-2022)
        7.3.5 GSK Key News
    7.4 Mylan
        7.4.1 Mylan Corporate Summary
        7.4.2 Mylan Business Overview
        7.4.3 Mylan Vaccine for Influenza Major Product Offerings
        7.4.4 Mylan Vaccine for Influenza Sales and Revenue in Global (2017-2022)
        7.4.5 Mylan Key News
    7.5 Hulan Bio
        7.5.1 Hulan Bio Corporate Summary
        7.5.2 Hulan Bio Business Overview
        7.5.3 Hulan Bio Vaccine for Influenza Major Product Offerings
        7.5.4 Hulan Bio Vaccine for Influenza Sales and Revenue in Global (2017-2022)
        7.5.5 Hulan Bio Key News
    7.6 AstraZeneca
        7.6.1 AstraZeneca Corporate Summary
        7.6.2 AstraZeneca Business Overview
        7.6.3 AstraZeneca Vaccine for Influenza Major Product Offerings
        7.6.4 AstraZeneca Vaccine for Influenza Sales and Revenue in Global (2017-2022)
        7.6.5 AstraZeneca Key News
    7.7 CCBIO
        7.7.1 CCBIO Corporate Summary
        7.7.2 CCBIO Business Overview
        7.7.3 CCBIO Vaccine for Influenza Major Product Offerings
        7.7.4 CCBIO Vaccine for Influenza Sales and Revenue in Global (2017-2022)
        7.7.5 CCBIO Key News
8 Global Vaccine for Influenza Production Capacity, Analysis
    8.1 Global Vaccine for Influenza Production Capacity, 2017-2028
    8.2 Vaccine for Influenza Production Capacity of Key Manufacturers in Global Market
    8.3 Global Vaccine for Influenza Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Vaccine for Influenza Supply Chain Analysis
    10.1 Vaccine for Influenza Industry Value Chain
    10.2 Vaccine for Influenza Upstream Market
    10.3 Vaccine for Influenza Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Vaccine for Influenza Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

List of Tables
    Table 1. Key Players of Vaccine for Influenza in Global Market
    Table 2. Top Vaccine for Influenza Players in Global Market, Ranking by Revenue (2021)
    Table 3. Global Vaccine for Influenza Revenue by Companies, (US$, Mn), 2017-2022
    Table 4. Global Vaccine for Influenza Revenue Share by Companies, 2017-2022
    Table 5. Global Vaccine for Influenza Sales by Companies, (K Units), 2017-2022
    Table 6. Global Vaccine for Influenza Sales Share by Companies, 2017-2022
    Table 7. Key Manufacturers Vaccine for Influenza Price (2017-2022) & (US$/Unit)
    Table 8. Global Manufacturers Vaccine for Influenza Product Type
    Table 9. List of Global Tier 1 Vaccine for Influenza Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Vaccine for Influenza Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Vaccine for Influenza Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Global Vaccine for Influenza Revenue (US$, Mn), 2017-2022
    Table 13. By Type - Global Vaccine for Influenza Revenue (US$, Mn), 2023-2028
    Table 14. By Type - Global Vaccine for Influenza Sales (K Units), 2017-2022
    Table 15. By Type - Global Vaccine for Influenza Sales (K Units), 2023-2028
    Table 16. By Application – Global Vaccine for Influenza Revenue, (US$, Mn), 2021 & 2028
    Table 17. By Application - Global Vaccine for Influenza Revenue (US$, Mn), 2017-2022
    Table 18. By Application - Global Vaccine for Influenza Revenue (US$, Mn), 2023-2028
    Table 19. By Application - Global Vaccine for Influenza Sales (K Units), 2017-2022
    Table 20. By Application - Global Vaccine for Influenza Sales (K Units), 2023-2028
    Table 21. By Region – Global Vaccine for Influenza Revenue, (US$, Mn), 2021 VS 2028
    Table 22. By Region - Global Vaccine for Influenza Revenue (US$, Mn), 2017-2022
    Table 23. By Region - Global Vaccine for Influenza Revenue (US$, Mn), 2023-2028
    Table 24. By Region - Global Vaccine for Influenza Sales (K Units), 2017-2022
    Table 25. By Region - Global Vaccine for Influenza Sales (K Units), 2023-2028
    Table 26. By Country - North America Vaccine for Influenza Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - North America Vaccine for Influenza Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - North America Vaccine for Influenza Sales, (K Units), 2017-2022
    Table 29. By Country - North America Vaccine for Influenza Sales, (K Units), 2023-2028
    Table 30. By Country - Europe Vaccine for Influenza Revenue, (US$, Mn), 2017-2022
    Table 31. By Country - Europe Vaccine for Influenza Revenue, (US$, Mn), 2023-2028
    Table 32. By Country - Europe Vaccine for Influenza Sales, (K Units), 2017-2022
    Table 33. By Country - Europe Vaccine for Influenza Sales, (K Units), 2023-2028
    Table 34. By Region - Asia Vaccine for Influenza Revenue, (US$, Mn), 2017-2022
    Table 35. By Region - Asia Vaccine for Influenza Revenue, (US$, Mn), 2023-2028
    Table 36. By Region - Asia Vaccine for Influenza Sales, (K Units), 2017-2022
    Table 37. By Region - Asia Vaccine for Influenza Sales, (K Units), 2023-2028
    Table 38. By Country - South America Vaccine for Influenza Revenue, (US$, Mn), 2017-2022
    Table 39. By Country - South America Vaccine for Influenza Revenue, (US$, Mn), 2023-2028
    Table 40. By Country - South America Vaccine for Influenza Sales, (K Units), 2017-2022
    Table 41. By Country - South America Vaccine for Influenza Sales, (K Units), 2023-2028
    Table 42. By Country - Middle East & Africa Vaccine for Influenza Revenue, (US$, Mn), 2017-2022
    Table 43. By Country - Middle East & Africa Vaccine for Influenza Revenue, (US$, Mn), 2023-2028
    Table 44. By Country - Middle East & Africa Vaccine for Influenza Sales, (K Units), 2017-2022
    Table 45. By Country - Middle East & Africa Vaccine for Influenza Sales, (K Units), 2023-2028
    Table 46. Sanofi Corporate Summary
    Table 47. Sanofi Vaccine for Influenza Product Offerings
    Table 48. Sanofi Vaccine for Influenza Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 49. CSL Corporate Summary
    Table 50. CSL Vaccine for Influenza Product Offerings
    Table 51. CSL Vaccine for Influenza Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 52. GSK Corporate Summary
    Table 53. GSK Vaccine for Influenza Product Offerings
    Table 54. GSK Vaccine for Influenza Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 55. Mylan Corporate Summary
    Table 56. Mylan Vaccine for Influenza Product Offerings
    Table 57. Mylan Vaccine for Influenza Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 58. Hulan Bio Corporate Summary
    Table 59. Hulan Bio Vaccine for Influenza Product Offerings
    Table 60. Hulan Bio Vaccine for Influenza Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 61. AstraZeneca Corporate Summary
    Table 62. AstraZeneca Vaccine for Influenza Product Offerings
    Table 63. AstraZeneca Vaccine for Influenza Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 64. CCBIO Corporate Summary
    Table 65. CCBIO Vaccine for Influenza Product Offerings
    Table 66. CCBIO Vaccine for Influenza Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 67. Vaccine for Influenza Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
    Table 68. Global Vaccine for Influenza Capacity Market Share of Key Manufacturers, 2020-2022
    Table 69. Global Vaccine for Influenza Production by Region, 2017-2022 (K Units)
    Table 70. Global Vaccine for Influenza Production by Region, 2023-2028 (K Units)
    Table 71. Vaccine for Influenza Market Opportunities & Trends in Global Market
    Table 72. Vaccine for Influenza Market Drivers in Global Market
    Table 73. Vaccine for Influenza Market Restraints in Global Market
    Table 74. Vaccine for Influenza Raw Materials
    Table 75. Vaccine for Influenza Raw Materials Suppliers in Global Market
    Table 76. Typical Vaccine for Influenza Downstream
    Table 77. Vaccine for Influenza Downstream Clients in Global Market
    Table 78. Vaccine for Influenza Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Vaccine for Influenza Segment by Type
    Figure 2. Vaccine for Influenza Segment by Application
    Figure 3. Global Vaccine for Influenza Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Vaccine for Influenza Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Vaccine for Influenza Revenue, 2017-2028 (US$, Mn)
    Figure 7. Vaccine for Influenza Sales in Global Market: 2017-2028 (K Units)
    Figure 8. The Top 3 and 5 Players Market Share by Vaccine for Influenza Revenue in 2021
    Figure 9. By Type - Global Vaccine for Influenza Sales Market Share, 2017-2028
    Figure 10. By Type - Global Vaccine for Influenza Revenue Market Share, 2017-2028
    Figure 11. By Type - Global Vaccine for Influenza Price (US$/Unit), 2017-2028
    Figure 12. By Application - Global Vaccine for Influenza Sales Market Share, 2017-2028
    Figure 13. By Application - Global Vaccine for Influenza Revenue Market Share, 2017-2028
    Figure 14. By Application - Global Vaccine for Influenza Price (US$/Unit), 2017-2028
    Figure 15. By Region - Global Vaccine for Influenza Sales Market Share, 2017-2028
    Figure 16. By Region - Global Vaccine for Influenza Revenue Market Share, 2017-2028
    Figure 17. By Country - North America Vaccine for Influenza Revenue Market Share, 2017-2028
    Figure 18. By Country - North America Vaccine for Influenza Sales Market Share, 2017-2028
    Figure 19. US Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
    Figure 20. Canada Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
    Figure 21. Mexico Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
    Figure 22. By Country - Europe Vaccine for Influenza Revenue Market Share, 2017-2028
    Figure 23. By Country - Europe Vaccine for Influenza Sales Market Share, 2017-2028
    Figure 24. Germany Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
    Figure 25. France Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
    Figure 26. U.K. Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
    Figure 27. Italy Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
    Figure 28. Russia Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
    Figure 29. Nordic Countries Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
    Figure 30. Benelux Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
    Figure 31. By Region - Asia Vaccine for Influenza Revenue Market Share, 2017-2028
    Figure 32. By Region - Asia Vaccine for Influenza Sales Market Share, 2017-2028
    Figure 33. China Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
    Figure 34. Japan Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
    Figure 35. South Korea Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
    Figure 36. Southeast Asia Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
    Figure 37. India Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
    Figure 38. By Country - South America Vaccine for Influenza Revenue Market Share, 2017-2028
    Figure 39. By Country - South America Vaccine for Influenza Sales Market Share, 2017-2028
    Figure 40. Brazil Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
    Figure 41. Argentina Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
    Figure 42. By Country - Middle East & Africa Vaccine for Influenza Revenue Market Share, 2017-2028
    Figure 43. By Country - Middle East & Africa Vaccine for Influenza Sales Market Share, 2017-2028
    Figure 44. Turkey Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
    Figure 45. Israel Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
    Figure 46. Saudi Arabia Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
    Figure 47. UAE Vaccine for Influenza Revenue, (US$, Mn), 2017-2028
    Figure 48. Global Vaccine for Influenza Production Capacity (K Units), 2017-2028
    Figure 49. The Percentage of Production Vaccine for Influenza by Region, 2021 VS 2028
    Figure 50. Vaccine for Influenza Industry Value Chain
    Figure 51. Marketing Channels
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
71
Frequently Asked Questions
Vaccine for Influenza Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Vaccine for Influenza Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Vaccine for Influenza Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports